Merck & Co., Inc: Crohn Disease trials
The registry lists 16 Crohn Disease studies with Merck & Co., Inc as lead sponsor. 2 are open to participants now and 10 have results posted.
Phase 2 1Phase 3 3Phase 4 1No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)RecruitingNCT06651281Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Phase 2a Safety and Efficacy Open-Label Study of Tulisokibart (MK-7240/PRA023) in Participants With Moderately to Severely Active Crohn's Disease (MK-7240-006)CompletedNCT05013905Phase 2Results posted
- Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)CompletedNCT01349920Results posted
- An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)CompletedNCT00988832Results posted
- Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)CompletedNCT00818272Results posted
- Remicade® Crohn's Disease Registry Across Canada (Study P02793)TerminatedNCT00755937Results posted
- Treatment With Infliximab in a Medical Setting (Study P05587)TerminatedNCT00752622Phase 4Results posted
- Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
- Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)CompletedNCT00724958Results posted
- Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)CompletedNCT00723840Results posted
- Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)CompletedNCT00705614Results posted
- Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)WithdrawnNCT01293656
- Observational Study of Disease Severity in Participants Diagnosed With Crohn's Disease and Long Term Impact of Treatment Strategies in Participants With Moderate to Severe Crohn's Disease (Protocol P06484)CompletedNCT01218360
- Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)TerminatedNCT00796250Phase 3
- Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)TerminatedNCT00705471